Resultados de la búsqueda 71-80 of 11952 for B cell lymphomas

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., Mankato, Minn., La Crosse ...

  2. Hematología - Ensayos clínicos

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  8. Hematología - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  10. Oncología (médica) - Ensayos clínicos

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study to Compare Somatostatin Analogues ...